114 related articles for article (PubMed ID: 3299308)
1. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
Wiecek A; Grzeszczak W
Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
[No Abstract] [Full Text] [Related]
2. [The effect of pharmacologic blockade of serotonin receptors (S2) on arterial pressure in rats with 2 forms of hereditary arterial hypertension].
Popova NK; Piianzin AI; Markel' AL
Farmakol Toksikol; 1989; 52(6):58-61. PubMed ID: 2516487
[TBL] [Abstract][Full Text] [Related]
3. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
Podoleanu D; Cotoi S
Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
[TBL] [Abstract][Full Text] [Related]
4. [Blockade of 5-HT2 receptors as a mechanism of antihypertensive action of ketanserin].
Prostran M
Srp Arh Celok Lek; 1994; 122(3-4):99-102. PubMed ID: 17972821
[TBL] [Abstract][Full Text] [Related]
5. [Serotonin and cardiovascular diseases. Pathophysiology and significance of serotonin antagonists].
Lüscher TF; Tanner FC; Bühler FR
Dtsch Med Wochenschr; 1992 Apr; 117(18):710-9. PubMed ID: 1572260
[No Abstract] [Full Text] [Related]
6. Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.
Blauw GJ; Doorenbos CJ; Bruning TA; van Brummelen P; van Zwieten PA
Drugs; 1990; 40 Suppl 4():42-4. PubMed ID: 1982654
[No Abstract] [Full Text] [Related]
7. Serotonergic type-2 (5-HT2) antagonists: a novel class of cardiovascular drugs.
Robertson JI
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S48-53. PubMed ID: 1717773
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of ketanserin in hypertension and vasospastic disease.
Wenting GJ; Brouwer RM; vd Meiracker AJ; Man in't Veld AJ; Schalekamp MA
Acta Cardiol; 1987; 42(5):339-54. PubMed ID: 2827406
[TBL] [Abstract][Full Text] [Related]
9. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
Vanhoutte P; Amery A; Birkenhäger W; Breckenridge A; Bühler F; Distler A; Dormandy J; Doyle A; Frohlich E; Hansson L
Hypertension; 1988 Feb; 11(2):111-33. PubMed ID: 3277910
[TBL] [Abstract][Full Text] [Related]
10. Ketanserin (S2-receptor blocking agents), hypertension and chronic alcoholism.
De Lorenzo A; Ceccanti M; Romeo M; Pisculli M; Di Giovanni MG; Lais A; Assogna G; Valgiusti FC
Int J Clin Pharmacol Res; 1986; 6(1):77-9. PubMed ID: 2937747
[TBL] [Abstract][Full Text] [Related]
11. The rationale for ketanserin therapy in hypertension.
Hansson L; Hedner T
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S39-44. PubMed ID: 2446068
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of the anti-hypertensive agent ketanserin in hypertension in man.
Weiss YA; Fournier V; Pannier B; Laurent S; Safar ME
Acta Cardiol; 1987; 42(5):329-37. PubMed ID: 3321806
[TBL] [Abstract][Full Text] [Related]
13. [Serotonin and its physiological and pathophysiological roles. Ketanserin].
Metelitsa TV
Kardiologiia; 1989 Sep; 29(9):120-5. PubMed ID: 2687555
[No Abstract] [Full Text] [Related]
14. [A new antihypertensive: ketanserin].
Salvini P
Riv Eur Sci Med Farmacol; 1989 Feb; 11(1):77-84. PubMed ID: 2678304
[TBL] [Abstract][Full Text] [Related]
15. [Ketanserin. Lowering blood pressure using serotonin antagonists].
Uhl D
Med Monatsschr Pharm; 1989 Oct; 12(10):298-301. PubMed ID: 2811738
[No Abstract] [Full Text] [Related]
16. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
[TBL] [Abstract][Full Text] [Related]
17. [Serotonin antagonists for the treatment of hypertension].
Bühler FR
Schweiz Med Wochenschr; 1988 Sep; 118(36):1259-60. PubMed ID: 3175572
[No Abstract] [Full Text] [Related]
18. [Serotoninergic receptors and cardiovascular diseases].
Hong E; Castillo C; Flores E; Mercedes F
Gac Med Mex; 1994; 130(3):131-3. PubMed ID: 7657075
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of the hypotensive effect of ketanserin.
Fozard JR
J Cardiovasc Pharmacol; 1982; 4(5):829-38. PubMed ID: 6182416
[No Abstract] [Full Text] [Related]
20. [Effect of a serotonin S2 receptor antagonist on portal hypertension due to cirrhosis. Preliminary results of a heart and liver hemodynamic study].
Deflandre J; Pirotte J; Etienne M; Carlier J
Ann Gastroenterol Hepatol (Paris); 1988; 24(3):103-5. PubMed ID: 3400992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
